Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore collagen lost due to aging. Collagen and HA provide essential support to skin and help it retain its elasticity. The glabellar lines, wrinkles, and lines can be reduced with facial aesthetic treatment.
Scope of the Report:
This report focuses on the Facial Injectables in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In terms of geographical regions, the Americas will be the major market contributor throughout the next few years. The US is the major revenue contributor in this region, where rapid advances in technology, the increasing awareness about aesthetic procedures, and the increasing demand for minimally invasive techniques, will bolster the market’s growth prospects.
Due the rise in preference of minimally invasive procedures, the botox segment dominated the market. The ease of treatment, accessibility to local providers, and the rise in success rates will result in an increasing number of people preferring botox. As a result, this segment will continue to dominate the market throughout the forecast period as well.
The worldwide market for Facial Injectables is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Allergan
Merz Aesthetics
Prollenium Medical Technologies
Bloomega BioTechnology
Galderma
Ipsen Group
Suneva Medical
Polymekon
Visionmed
Syneron
Medytox
AQTIS Medical
ColBar LifeScience
SciVision Biotech
Hangzhou Techderm Biological Products
Qufu Guanglong Biochem
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Botox
Dermal Fillers
Other
Market Segment by Applications, can be divided into
Hospitals
Clinics
Cosmetic Centers
Other
There are 15 Chapters to deeply display the global Facial Injectables market.
Chapter 1, to describe Facial Injectables Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Facial Injectables, with sales, revenue, and price of Facial Injectables, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Facial Injectables, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Facial Injectables market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Facial Injectables sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Facial Injectables Introduction
1.2 Market Analysis by Type
1.2.1 Botox
1.2.2 Dermal Fillers
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Cosmetic Centers
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Facial Injectables Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merz Aesthetics
2.2.1 Business Overview
2.2.2 Facial Injectables Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merz Aesthetics Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Prollenium Medical Technologies
2.3.1 Business Overview
2.3.2 Facial Injectables Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Prollenium Medical Technologies Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bloomega BioTechnology
2.4.1 Business Overview
2.4.2 Facial Injectables Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bloomega BioTechnology Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Galderma
2.5.1 Business Overview
2.5.2 Facial Injectables Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Galderma Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ipsen Group
2.6.1 Business Overview
2.6.2 Facial Injectables Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ipsen Group Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Suneva Medical
2.7.1 Business Overview
2.7.2 Facial Injectables Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Suneva Medical Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Polymekon
2.8.1 Business Overview
2.8.2 Facial Injectables Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Polymekon Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Visionmed
2.9.1 Business Overview
2.9.2 Facial Injectables Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Visionmed Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Syneron
2.10.1 Business Overview
2.10.2 Facial Injectables Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Syneron Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Medytox
2.11.1 Business Overview
2.11.2 Facial Injectables Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Medytox Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 AQTIS Medical
2.12.1 Business Overview
2.12.2 Facial Injectables Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 AQTIS Medical Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 ColBar LifeScience
2.13.1 Business Overview
2.13.2 Facial Injectables Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 ColBar LifeScience Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 SciVision Biotech
2.14.1 Business Overview
2.14.2 Facial Injectables Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 SciVision Biotech Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Hangzhou Techderm Biological Products
2.15.1 Business Overview
2.15.2 Facial Injectables Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Hangzhou Techderm Biological Products Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Qufu Guanglong Biochem
2.16.1 Business Overview
2.16.2 Facial Injectables Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Qufu Guanglong Biochem Facial Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Facial Injectables Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Facial Injectables Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Facial Injectables Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Facial Injectables Manufacturer Market Share in 2017
3.3.2 Top 6 Facial Injectables Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Facial Injectables Market Analysis by Regions
4.1 Global Facial Injectables Sales, Revenue and Market Share by Regions
4.1.1 Global Facial Injectables Sales and Market Share by Regions (2013-2018)
4.1.2 Global Facial Injectables Revenue and Market Share by Regions (2013-2018)
4.2 North America Facial Injectables Sales and Growth Rate (2013-2018)
4.3 Europe Facial Injectables Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Facial Injectables Sales and Growth Rate (2013-2018)
4.5 South America Facial Injectables Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Facial Injectables Sales and Growth Rate (2013-2018)
5 North America Facial Injectables by Countries
5.1 North America Facial Injectables Sales, Revenue and Market Share by Countries
5.1.1 North America Facial Injectables Sales and Market Share by Countries (2013-2018)
5.1.2 North America Facial Injectables Revenue and Market Share by Countries (2013-2018)
5.2 United States Facial Injectables Sales and Growth Rate (2013-2018)
5.3 Canada Facial Injectables Sales and Growth Rate (2013-2018)
5.4 Mexico Facial Injectables Sales and Growth Rate (2013-2018)
6 Europe Facial Injectables by Countries
6.1 Europe Facial Injectables Sales, Revenue and Market Share by Countries
6.1.1 Europe Facial Injectables Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Facial Injectables Revenue and Market Share by Countries (2013-2018)
6.2 Germany Facial Injectables Sales and Growth Rate (2013-2018)
6.3 UK Facial Injectables Sales and Growth Rate (2013-2018)
6.4 France Facial Injectables Sales and Growth Rate (2013-2018)
6.5 Russia Facial Injectables Sales and Growth Rate (2013-2018)
6.6 Italy Facial Injectables Sales and Growth Rate (2013-2018)
7 Asia-Pacific Facial Injectables by Countries
7.1 Asia-Pacific Facial Injectables Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Facial Injectables Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Facial Injectables Revenue and Market Share by Countries (2013-2018)
7.2 China Facial Injectables Sales and Growth Rate (2013-2018)
7.3 Japan Facial Injectables Sales and Growth Rate (2013-2018)
7.4 Korea Facial Injectables Sales and Growth Rate (2013-2018)
7.5 India Facial Injectables Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Facial Injectables Sales and Growth Rate (2013-2018)
8 South America Facial Injectables by Countries
8.1 South America Facial Injectables Sales, Revenue and Market Share by Countries
8.1.1 South America Facial Injectables Sales and Market Share by Countries (2013-2018)
8.1.2 South America Facial Injectables Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Facial Injectables Sales and Growth Rate (2013-2018)
8.3 Argentina Facial Injectables Sales and Growth Rate (2013-2018)
8.4 Colombia Facial Injectables Sales and Growth Rate (2013-2018)
9 Middle East and Africa Facial Injectables by Countries
9.1 Middle East and Africa Facial Injectables Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Facial Injectables Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Facial Injectables Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Facial Injectables Sales and Growth Rate (2013-2018)
9.3 UAE Facial Injectables Sales and Growth Rate (2013-2018)
9.4 Egypt Facial Injectables Sales and Growth Rate (2013-2018)
9.5 Nigeria Facial Injectables Sales and Growth Rate (2013-2018)
9.6 South Africa Facial Injectables Sales and Growth Rate (2013-2018)
10 Global Facial Injectables Market Segment by Type
10.1 Global Facial Injectables Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Facial Injectables Sales and Market Share by Type (2013-2018)
10.1.2 Global Facial Injectables Revenue and Market Share by Type (2013-2018)
10.2 Botox Sales Growth and Price
10.2.1 Global Botox Sales Growth (2013-2018)
10.2.2 Global Botox Price (2013-2018)
10.3 Dermal Fillers Sales Growth and Price
10.3.1 Global Dermal Fillers Sales Growth (2013-2018)
10.3.2 Global Dermal Fillers Price (2013-2018)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2013-2018)
10.4.2 Global Other Price (2013-2018)
11 Global Facial Injectables Market Segment by Application
11.1 Global Facial Injectables Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Cosmetic Centers Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Facial Injectables Market Forecast (2018-2023)
12.1 Global Facial Injectables Sales, Revenue and Growth Rate (2018-2023)
12.2 Facial Injectables Market Forecast by Regions (2018-2023)
12.2.1 North America Facial Injectables Market Forecast (2018-2023)
12.2.2 Europe Facial Injectables Market Forecast (2018-2023)
12.2.3 Asia-Pacific Facial Injectables Market Forecast (2018-2023)
12.2.4 South America Facial Injectables Market Forecast (2018-2023)
12.2.5 Middle East and Africa Facial Injectables Market Forecast (2018-2023)
12.3 Facial Injectables Market Forecast by Type (2018-2023)
12.3.1 Global Facial Injectables Sales Forecast by Type (2018-2023)
12.3.2 Global Facial Injectables Market Share Forecast by Type (2018-2023)
12.4 Facial Injectables Market Forecast by Application (2018-2023)
12.4.1 Global Facial Injectables Sales Forecast by Application (2018-2023)
12.4.2 Global Facial Injectables Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Facial Injectables Picture
Table Product Specifications of Facial Injectables
Figure Global Sales Market Share of Facial Injectables by Types in 2017
Ta